| Literature DB >> 35719050 |
Evan Gates1, Bing-Hao Chiang1, Alan Kalet1, Minsun Kim1.
Abstract
PURPOSE: To evaluate the impact of a digital whiteboard system integrated with data from the oncology information system (OIS) on the urgency of physics quality assurance (QA) tasks in the radiation oncology department.Entities:
Keywords: quality assurance; standardization; whiteboard
Mesh:
Year: 2022 PMID: 35719050 PMCID: PMC9278682 DOI: 10.1002/acm2.13703
Source DB: PubMed Journal: J Appl Clin Med Phys ISSN: 1526-9914 Impact factor: 2.243
Descriptions of each step in the integrated whiteboard system and corresponding quality check list (QCL) items
| QCL | Responsible | Description |
|---|---|---|
|
| Dosimetrist | CT scan export to treatment planning system |
|
| Physician | Contouring of target volumes and organs‐at‐risk |
|
| Dosimetrist | Treatment plan generation |
|
| Physician | Review and approval of treatment plan |
|
| Dosimetrist | Plan and beam parameters export to OIS |
|
| Physicist | Patient‐specific QA if needed |
|
| Physicist | Initial plan check |
|
| Therapist | Final pretreatment check |
FIGURE 1Schematic of the whiteboard application showing color‐coded cards representing patients
Urgency levels for QAs that put increased pressure on physics
| Urgency level | QA required by next day | QA available after 3:00 PM | Patient treats before 10:00 AM |
|---|---|---|---|
|
| × | ||
|
| × | × | |
|
| × | × | |
|
| × | × | × |
QA, Quality Assurance; IMRT, Intensity modulated radiation therapy; VMAT, Volumetric arc therapy; SBRT, Stereotactic body radiation therapy.
Number of urgent plans by time available for physics QA and treatment start time before and after whiteboard implementation. p‐Values are from Fisher's exact test on the proportions (ND: next day).
| Before: Jan 2019–Dec 2019 | After: Jul 2020–Jun 2021 | ||||
|---|---|---|---|---|---|
| Total QA | 797 | 765 |
| ||
| Total ND | 374 | 46.9% | 263 | 34.4% | <0.001 |
| Urgency 1 | 184 | 23.1% | 125 | 16.3% | <0.001 |
| Urgency 2 | 122 | 15.3% | 100 | 13.1% | 0.39 |
| Urgency 3 | 38 | 4.8% | 25 | 3.3% | 0.16 |
| Urgency 4 | 30 | 3.8% | 13 | 1.7% | 0.01 |
QA, Quality Assurance; ND, next‐day.
Number of urgent plans separated by the day of the week they were available for QA. The values are plotted in Figure 2. QCLs available on weekends were excluded. p‐Values are from Fisher's exact test on the proportions of next‐day QAs.
| Before: Jan 2019–Dec 2019 | After: Jul 2020–Jun 2021 | ||||||
|---|---|---|---|---|---|---|---|
| QA available day | Total | # ND | % ND | Total | # ND | % ND |
|
| Monday | 163 | 76 | 46.6% | 133 | 47 | 35.3% | 0.06 |
| Tuesday | 161 | 100 | 62.1% | 151 | 55 | 36.4% | <0.001 |
| Wednesday | 133 | 65 | 48.9% | 132 | 49 | 37.1% | 0.06 |
| Thursday | 152 | 28 | 18.4% | 167 | 30 | 18.0% | 1.00 |
| Friday | 174 | 98 | 56.3% | 180 | 82 | 45.6% | 0.04 |
QA, Quality Assurance; ND, next‐day.
FIGURE 2Proportional decrease in next‐day quality assurances (QAs) overall, for different urgency levels, and for relevant subsets. Each bar is the proportion of overall plans with the specific numbers listed above. Percentages above each pair of bars are the percent change in the proportion before and after whiteboard implementation. Significance is indicated: ***, **, *,
Number of urgent plans separated by time of year. The values are plotted in Figure 2c. p‐values are from Fisher's exact test on the proportions of next‐day QAs.
| Before: Jan 2019–Dec 2019 | After: Jul 2020–Jun 2021 | ||||||
|---|---|---|---|---|---|---|---|
| Month block | Total | # ND | % ND | Total | # ND | % ND |
|
| Jan–Mar | 172 | 74 | 43.0% | 186 | 64 | 34.4% | 0.10 |
| Apr–Jun | 214 | 100 | 46.7% | 195 | 73 | 37.4% | 0.07 |
| Jul–Sept | 198 | 92 | 46.5% | 198 | 70 | 35.4% | 0.03 |
| Oct–Dec | 213 | 108 | 50.7% | 186 | 56 | 30.1% | <0.001 |
QA, Quality Assurance; ND, next‐day.
Number of urgent plans separated by type of plan. The values are plotted in Figure 2d,e. p‐Values are from Fisher's exact test on the proportions of next‐day QAs
| Before: Jan 2019–Dec 2019 | After: Jul 2020–Jun 2021 | ||||||
|---|---|---|---|---|---|---|---|
| Plan type | Total | # ND | % ND | Total | # ND | % ND |
|
| SBRT‐IMRT | 34 | 19 | 55.9% | 56 | 27 | 48.2% | 0.52 |
| IMRT | 113 | 55 | 48.7% | 119 | 46 | 38.7% | 0.15 |
| SBRT‐VMAT | 225 | 96 | 42.7% | 158 | 51 | 32.3% | 0.04 |
| VMAT | 425 | 204 | 48.0% | 432 | 139 | 32.2% | <0.001 |
| SBRT | 260 | 115 | 44.2% | 214 | 78 | 36.4% | 0.09 |
| Non‐SBRT | 538 | 259 | 48.1% | 551 | 185 | 33.6% | <0.001 |
| IMRT | 147 | 74 | 50.3% | 175 | 73 | 41.7% | 0.14 |
| VMAT | 650 | 300 | 46.2% | 590 | 190 | 32.2% | <0.001 |
QA, Quality Assurance; ND, next‐day; IMRT, Intensity modulated radiation therapy; VMAT, Volumetric arc therapy; SBRT, Stereotactic body radiation therapy.